New synthetic raloxifen-like di(hetero)arylamines induce apoptosis and inhibit the estrogen receptor in breast cancer cells
Breast cancer is the most common form of cancer in women in the western world, and in spite of some decline in death rates in recent years it is still the second most common cause of death from cancer, in women (1). For more than three decades, the estrogen receptor (ER) has been the most important...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , |
| Formato: | conferenceObject |
| Idioma: | eng |
| Publicado em: |
2011
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/1822/15778 |
| País: | Portugal |
| Oai: | oai:repositorium.sdum.uminho.pt:1822/15778 |